Comparison of Insulin Diluent Leakage Postinjection using two diferent needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 6, Issue 2, 2012, Pages 389-393

  Ignaut, Debra A ^a   Fu, Haoda ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Diabetes; Leakage; Needle length; Obesity

Indexed keywords

DILUENT; INSULIN; INSULIN DILUENT; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; FEMALE; HUMAN; INJECTION SITE; INJECTION SITE BLEEDING; INJECTION SITE CONTUSION; INJECTION SITE LEAKAGE; INJECTION SITE PAIN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INJECTION PEN; MAJOR CLINICAL STUDY; MALE; NEEDLE LENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYRINGE NEEDLE; WEIGHT, MASS AND SIZE; AGED; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; HEMATOMA; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; NEEDLE; PAIN; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

AGED; BODY MASS INDEX; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; HEMATOMA; HEMORRHAGE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; NEEDLES; OBESITY; PAIN; SINGLE-BLIND METHOD; UNITED STATES;

EID: 84865146994     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600226     Document Type: Article

References (11)

1. Polonsky WH, Jackson RA. What's So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes. Clin Diabetes. 2004;22(3):147-50.
2. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(10):1663-78. (Pubitemid 39643027)
3. Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, Letondeur C, Sauvanet JP, Tubiana-Rufi N, Strauss K; Scientific Advisory Board for the Third Injection Technique Workshop. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36 Suppl 2:S3-18.
4. Strauss K, Hannet I, McGonigle J, Parkes JL, Ginsberg B, Jamal R, Frid A. Ultra-short (5 mm) insulin needles: Trial results and clinical recommendations. Pract Diabetes Int. 1999;16(7):218-22. (Pubitemid 29533163)
5. Kreugel G, Keers JC, Jongbloed A, Verweij-Gjaltema AH, Wolfenbuttel BHR. The Influence of Needle Length on Glycemic Control and Patient Preference in Obese Diabetic Patients [abstract 440-P]. Diabetes. 2009;58 Suppl 1.
6. Ross SA, Jamal R, Leiter LA, Josse RG, Parkes JL, Qu S, Kerestan SP, Ginsberg BH. Evaluation of 8 mm insulin pen needles in people with type 1 and type 2 diabetes. Pract Diabetes Int. 1999;16(5):145-8. (Pubitemid 29410623)
7. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149-58. (Pubitemid 33016608)
8. Hardy JD, Wolf HG, Goodell H. Pain Sensations and Reactions. Baltimore: Williams & Wilkins; 1952.
9. Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed in pain intensity measurement? Pain. 1994;58(3):387-92. (Pubitemid 24284081)
10. Jensen MP, Miller L, Fisher LD. Assessment of pain during medical procedures: a comparison of three scales. Clin J Pain. 1998;14(4):343-9. (Pubitemid 28560158)
11. Peters ML, Patijn J, Lamé I. Pain assessment in younger and older pain patients: psychometric properties and patient preference of five commonly used measures of pain intensity. Pain Med. 2007;8(7):601-10. (Pubitemid 47490215)